ABHD17A has been reported to exert depalmitoylase activity for 10 years, it participates in multiple biological processes such as cancer growth, synapse development, and inflammation by removing palmitoyl groups from substrates [21,22,24,25,37]. The gene discussed is ABHD17A; the disease is cancer.